Clinical Trial Update: FX-322 in Adults With Acquired Sensorineural Hearing Loss [Phase 2]

View source ↗

Summary

Phase 2 trial update for FX-322 in adults with sensorineural hearing loss shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss
• Noise-induced Hearing Loss
• Sensorineural Hearing Loss
• Sudden Hearing Loss

Drugs mentioned

• FX-322

Snippet

Sponsor: Frequency Therapeutics | Conditions: Hearing Loss, Sensorineural, Noise Induced Hearing Loss | Phase 2 | Status: COMPLETED | Results posted: 2023-04-21